Our observations support the importance of cholesterol for the growth of prostate cancer cell lines: 1) increase in cell number relative to control after treatment with increasing concentrations of LDL; 2) decreased relative cell number after inhibition of intracellular cholesterol synthesis with simvastatin, which could be prevented by addition of LDL; 3) enhanced expression of HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynhesis at baseline in cancer cell lines and 4) no evidence of ABCA1 expression in cancer cells under any circumstances, even after LDL treatment. Here, HMGCR is linked to prostate carcinoma.